24.10.2012 Views

Investor Update November 2009 (241 kb) - British American Tobacco

Investor Update November 2009 (241 kb) - British American Tobacco

Investor Update November 2009 (241 kb) - British American Tobacco

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>British</strong> <strong>American</strong><br />

<strong>Tobacco</strong><br />

<strong>Investor</strong> update<br />

<strong>November</strong> <strong>2009</strong><br />

www.bat.com


Note to recipients<br />

This document has been prepared solely for use at a presentation to be held in connection with the proposed offering and sale of securities of B.A.T. International Finance p.l.c. (the “Issue”).<br />

The information contained in this document has not been independently verified and no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the information or opinions<br />

contained herein. The information set out herein may be subject to revision and may change materially before closing. <strong>British</strong> <strong>American</strong> <strong>Tobacco</strong> is under no obligation to keep current the information contained in<br />

this document and any opinions expressed in it are subject to change without notice. Prospective investors are solely responsible for making their own independent appraisal of and investigations into the products,<br />

investments and transactions referred to in this document and should not rely on any information in this document as constituting investment advice. Neither <strong>British</strong> <strong>American</strong> <strong>Tobacco</strong> nor any of its affiliates are<br />

responsible for providing you with legal, tax or other specialist advice and you should make your own arrangements in this respect accordingly. This document is an advertisement and not a prospectus, and<br />

prospective investors should not rely upon this document in making any investment decision, and should rely only on the final version of the Base Prospectus, which will contain material information not in this<br />

document. The Issue involves particular risks – prospective investors should read and understand the explanations of risk in the final versions of the Base Prospectus before making any decisions. Nothing<br />

contained herein shall form the basis of any contract or commitment whatsoever, and except in the case of fraudulent misrepresentation, none of <strong>British</strong> <strong>American</strong> <strong>Tobacco</strong> or any of its affiliates, advisers or<br />

representatives shall have any liability whatsoever for any loss whatsoever arising from any use of this document or its contents, or otherwise arising in connection with this document (whether direct, indirect,<br />

consequential or other).<br />

Unauthorised distribution of the information contained in this document may constitute an offence (and, in particular, such unauthorised distribution in the UK may constitute an offence under the Financial Services<br />

and Markets Act 2000 (“FSMA”)). The content of this document has not been approved by the UK Financial Services Authority ("FSA") or any person authorised under the FSMA. Accordingly, the document is<br />

directed only at persons whom are sufficiently expert or sufficiently substantial to understand the risks involved in entering into the proposed transaction (each being, (i) in case the of recipients in the EEA, ‘qualified<br />

investors’ within the meaning of the Prospectus Directive (2003/71/EC); and (ii) in addition, in the case of recipients in the UK, persons whom <strong>British</strong> <strong>American</strong> <strong>Tobacco</strong> reasonably believes to be: (i) persons who<br />

have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”); or (ii) persons falling within<br />

Article 49(2)(a) to (d) of the Order or to those persons to whom it can otherwise lawfully be distributed (all such persons together being referred to as “relevant persons”)). The document is directed only at such<br />

relevant persons, and if you are not such a relevant person, you must not rely on the Information and you must return it immediately. Any investment or investment activity to which this communication relates is<br />

available only to relevant persons and will be engaged in only with relevant persons. This document also is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such<br />

distribution or use would be contrary to law or regulation. In particular, this document and the information contained herein do not constitute an offer of securities for sale in the United States and are not for<br />

publication or distribution to persons in the United States (within the meaning of Regulation S under the United States Securities Act of 1933, as amended (the “Securities Act”)). The securities proposed to be offered<br />

in the Issue have not been, and will not be, registered under the Securities Act and may not be offered or sold in the United States or for the account or benefit of, US persons (as defined in Regulation S under the<br />

Securities Act) except in accordance with Regulation S under the Securities Act or pursuant to an exemption from the registration requirements of the Securities Act.<br />

Neither this document nor any copy of it may be taken or transmitted into the United States, its territories or possessions, or distributed, directly or indirectly, in the United States, its territories or possessions. The<br />

distribution of this document in other jurisdictions may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions.<br />

The information in this document is confidential. Distribution of this document, or information in this document, to any person other than an original recipient (or to such recipient’s advisors) is prohibited.<br />

Reproduction of this document, in whole or in part, or disclosure of any of its contents is prohibited. This document should be distributed and read in its entirety. This document remains the property of <strong>British</strong><br />

<strong>American</strong> <strong>Tobacco</strong> and on request must be returned and any copies destroyed.<br />

This document is for information and convenient reference and is not intended as an offer for sale or subscription of, or solicitation of any offer to buy or subscribe for, any securities of <strong>British</strong> <strong>American</strong> <strong>Tobacco</strong> nor<br />

should it or any part of it form the basis of, or be relied on in connection with, any contract or commitment whatsoever. There shall be no sale of these securities in any state or jurisdiction in which such offer,<br />

solicitation or sale would be unlawful prior to qualification under securities laws of such state or jurisdiction.<br />

This document includes ‘forward-looking statements’. These statements contain the words “anticipate”, “believe”, “intend”, “estimate”, “expect” and words of similar meaning. All statements other than statements of<br />

historical fact included in this document, including, without limitation, those regarding <strong>British</strong> <strong>American</strong> <strong>Tobacco</strong>'s financial position, business strategy, plans and objectives of management for future operations are<br />

forward-looking statements. Any projection, forecast, estimate or other ‘forward-looking’ statement in this document only illustrates hypothetical performance under specified assumptions of events or conditions,<br />

which may include (but are not limited to) prepayment expectations, interest rates, collateral and volatility. Such projections, forecasts, estimates or other ‘forward-looking’ statements are not reliable indicators of<br />

future performance. As with any mathematical model that calculates results from inputs, results may vary significantly according to the values input. Prospective investors should understand the assumptions and<br />

evaluate whether they are appropriate for their purposes. Some relevant events or conditions may not have been considered in such assumptions. Actual events or conditions may differ materially from<br />

assumptions. The document may include figures related to past performance or simulated past performance (together “past performance”). Past performance is not a reliable indicator of future performance. <strong>British</strong><br />

<strong>American</strong> <strong>Tobacco</strong> disclaims any obligation to update their view of such risks and uncertainties or to publicly announce the result of any revisions to the forward-looking statements made herein, except where they<br />

would be required to do so under applicable law.<br />

By receiving this document you will be taken to have represented, warranted and undertaken that: (i) you are a relevant person (as defined above); (ii) you have read and agree to comply with the contents of this<br />

notice; and (iii) you will not at any time have any discussion, correspondence or contact concerning the information in this document or the transaction with any of the directors or employees of <strong>British</strong> <strong>American</strong><br />

<strong>Tobacco</strong> nor with any of their suppliers, customers, subcontractors or any governmental or regulatory body without the prior written consent of <strong>British</strong> <strong>American</strong> <strong>Tobacco</strong>. By receiving or attending the presentation<br />

you agree to be bound by the foregoing terms, and to keep this document and the information contained herein confidential.<br />

NOT FOR DISTRIBUTION INTO THE UNITED STATES OF AMERICA<br />

1


Agenda<br />

� Business overview<br />

� Group strategy update<br />

� Key highlights<br />

� Financial overview<br />

� Summary<br />

2


BAT Overview<br />

� A leading global tobacco company by global market share<br />

� Market cap of £39.2bn as of <strong>November</strong> 4, <strong>2009</strong><br />

� Clear and consistent business strategy<br />

� Strong cash flow and liquidity position<br />

� Excellent geographic diversity<br />

� Leadership position in more than 50 markets<br />

� Decline in mature markets offset by growth in emerging markets<br />

� Powerful portfolio of leading brands<br />

� Strong brands matched to market requirements<br />

� Four Global Drive Brands: Lucky Strike, Kent, Dunhill, Pall Mall<br />

3


Major Competitors<br />

BAT*<br />

PMI<br />

JTI<br />

Imperial<br />

CNTC<br />

Others<br />

*BAT excludes associates<br />

2008 World Market Shares %<br />

5.4<br />

12.9<br />

11.1<br />

15.7<br />

15.1<br />

39.8<br />

More than 70% of<br />

the world market<br />

excluding China<br />

4


Excellent geographic diversity with<br />

exposure to growing emerging markets<br />

Profitability by region 2008* Volumes by markets** 2008<br />

14%<br />

20%<br />

13%<br />

32%<br />

21%<br />

Europe Asia-Pacific<br />

Latin America Africa & M East<br />

America-Pacific<br />

Source: 2008 report and accounts<br />

* Profit from operations excluding unallocated costs,<br />

exceptional items, restructuring costs and gains on disposals<br />

76%<br />

24%<br />

Developed Markets<br />

Developing Markets<br />

Source: Internal company analysis<br />

** Countries are allocated to developed and developing<br />

markets based on the World Bank’s categorisation<br />

5


Business Strategy<br />

VISION<br />

STRATEGY<br />

GROWTH PRODUCTIVITY<br />

� Organic Growth<br />

- Key Segments & Brands<br />

- Innovation<br />

- Priority Markets<br />

� Mergers & Acquisitions<br />

WINNING ORGANISATION<br />

� Great Place to Work<br />

- Leadership<br />

-Culture<br />

ACHIEVE<br />

LEADERSHIP OF<br />

THE GLOBAL<br />

TOBACCO INDUSTRY<br />

� Smart Cost<br />

Management<br />

- Supply Chain<br />

- Overheads & Indirects<br />

� Marketing Efficiency<br />

� Capital Effectiveness<br />

RESPONSIBILITY<br />

� Business<br />

Principles<br />

� Outstanding People<br />

-Talent<br />

- Learning<br />

� Standards of<br />

Business Conduct<br />

� Sensible Regulation<br />

� Harm Reduction<br />

6


Volume (Billions)<br />

Growth: Global Drive Brands<br />

200<br />

180<br />

160<br />

140<br />

120<br />

100<br />

80<br />

60<br />

40<br />

20<br />

0<br />

78<br />

85<br />

Pall Mall Dunhill Kent Lucky Strike<br />

93 100<br />

Source: Internal company analysis<br />

10.1% CAGR<br />

113<br />

114<br />

125<br />

146<br />

161<br />

1999<br />

2000<br />

2001<br />

2002<br />

2003<br />

2004<br />

2005<br />

2006<br />

2007<br />

2008<br />

187<br />

136 142<br />

2008 Q3<br />

<strong>2009</strong> Q3<br />

7


Growth: Innovation<br />

� There is a continuous emphasis on developing and rolling out brand and<br />

product innovations, focusing on GDBs:<br />

� formats e.g. Kent Nanotek<br />

� packaging Re-sealable<br />

� menthol Kool Boost<br />

� charcoal Kent 3Tek<br />

� limited edition packs Lucky Strike Window Pack<br />

Global Drive Brands: Dunhill, Kent, Pall Mall, Lucky Strikes<br />

8


Mergers & Acquisitions<br />

� Solid track record of strategic acquisitions:<br />

� STK Cigarette & Snus business in Denmark 2008<br />

� Tekel in Turkey in 2008<br />

� Bentoel in Indonesia in <strong>2009</strong><br />

� BAT continues to explore M&A opportunities which provide<br />

a good strategic fit and meet relevant financial criteria<br />

9


Productivity savings goal: 2008 – 2012<br />

� A significant driver of profit growth<br />

� Some drop through to the bottom line<br />

� Balance reinvested in the business<br />

� Target of a further £800mn by 2012<br />

� Past savings of £1bn over 5 years in 2007<br />

� Savings from supply chain, overheads & indirects<br />

� Supply chain efficiencies<br />

� Back office integration<br />

� Management structures<br />

10


Responsibility Strategy<br />

� Business principles rolled out in all markets<br />

� Corporate Social Responsibility reporting covering 40 countries<br />

accounting for over 70% of our volume<br />

� Ongoing stakeholder dialogue<br />

� External recognition: e.g., inclusion in the Dow Jones Sustainability<br />

Index, <strong>2009</strong> UK Business in the Community Corporate Responsibility<br />

Index<br />

� Publication of a sustainability report<br />

11


Regulation update<br />

� WHO’s Framework Convention on <strong>Tobacco</strong> Control<br />

(FCTC) in force, ratified by over 160 governments<br />

� Further tobacco control and tobacco-related<br />

regulation will happen, driven by the FCTC and<br />

domestic regulation, such as:<br />

� Product e.g. product design requirements<br />

� Packaging e.g. graphic health warnings on packs<br />

� Promotion e.g. consumer communication restrictions<br />

� Purchase e.g. product display restrictions<br />

� Place e.g. public place smoking bans<br />

� Price e.g. excise increases<br />

� May impact overall sales volume and the cost of doing<br />

business<br />

12


<strong>Tobacco</strong> Litigation <strong>Update</strong><br />

� Historical<br />

� Largest litigation threat in USA<br />

� Overwhelming majority of cases in industry’s favour<br />

� Healthcare recoupment cases<br />

� Canada<br />

� Nigeria<br />

� Class Actions<br />

� Individual Cases<br />

13


Financial policies<br />

� Liquidity : maintain minimum of £1bn in cash<br />

and committed facilities<br />

� Maturity profile : average maturity of 5 years<br />

� Gross interest cover : between 5 and 9 times<br />

� Dividends : distribute 65% of long term<br />

sustainable earnings<br />

� Share repurchase : £750mn in 2007, £400mn in 2008<br />

currently suspended<br />

14


Ratings update<br />

� Ratings strategy:<br />

� Target Baa1 / BBB+<br />

� No lower than Baa2 / BBB<br />

� Ratings affirmed after the Bentoel acquisition<br />

Moody’s S&P Fitch<br />

LT Rating Baa1 BBB+ BBB+<br />

ST Rating P-2 A-2 F2<br />

Outlook Stable Stable Stable<br />

15


£ mn<br />

2,000<br />

1,800<br />

1,600<br />

1,400<br />

1,200<br />

1,000<br />

800<br />

600<br />

400<br />

200<br />

Debt maturities as at 4 th <strong>November</strong> <strong>2009</strong><br />

-<br />

2010<br />

2011<br />

2012<br />

Average Group maturity Maturity Profile = 5.3 yrs<br />

2013<br />

2014<br />

2015<br />

2016<br />

2017<br />

Bonds Bank Facilities<br />

2018<br />

2019<br />

2022<br />

2024<br />

2029<br />

16


Market Access & Liquidity<br />

� Good access to bank market<br />

� £ 1.75bn un-drawn committed credit facilities<br />

� Refinanced € 700mn committed facilities in July <strong>2009</strong> to 2012<br />

� All major bond markets available<br />

� GBP, EUR, USD<br />

� Re-established ECP programme in <strong>2009</strong><br />

� Strong cash flow & cash balance<br />

17


Liability Management Exercise<br />

� On 4 th Nov BNP Paribas announced a tender of the<br />

outstanding BAT EUR & GBP 2013s<br />

� New longer-dated EUR & GBP issues planned, to be led by<br />

Barclays Capital, BNP Paribas, RBS and SG CIB subject to<br />

market conditions<br />

� This exercise aims to reduce the debt maturity spike in<br />

2013, extend the maturity of our debt portfolio and take<br />

advantage of current long-term rates<br />

18


Financial Highlights<br />

£mn FY2007 FY2008 2008H1 <strong>2009</strong>H1<br />

Volume (Bns) 684 715 334 349<br />

External NTO 10,018 12,122 6,454 6,780<br />

Operating Profit 3,002 3,717 1,757 2,164<br />

Operating Profit Margin 30% 31% 27% 32%<br />

EBITDA* 3,316 4,118 1,926 2,418<br />

EBITDA Margin 33% 34% 30% 36%<br />

Net Debt 5,665 9,852 7,329 9,587<br />

* EBITDA is adjusted to exclude exceptional items<br />

19


Profit from operations<br />

Regions FY2007 FY2008<br />

£mn £mn<br />

Europe 842 1,213<br />

Asia Pacific 672 804<br />

Latin America 681 759<br />

Africa Middle East 467 536<br />

America Pacific 446 515<br />

Total 3,108 3,827<br />

Unallocated Costs -106 -110<br />

Profit (Excluding exceptional items) 3,002 3,717<br />

Exceptional items -98 -145<br />

Profit from operations 2,904 3,572<br />

20


Profit from operations<br />

Regions 2008H1 <strong>2009</strong>H1<br />

£mn £mn<br />

Asia Pacific 456 557<br />

Americas 516 579<br />

Western Europe 334 509<br />

Eastern Europe 199 183<br />

Africa Middle East 252 336<br />

Total 1,757 2,164<br />

Unallocated Costs 0 0<br />

Profit (Excluding exceptional items) 1,757 2,164<br />

Exceptional items -33 -53<br />

Profit from operations 1,724 2,111<br />

21


Cash Flow<br />

£mn FY2007 FY2008 2008H1 <strong>2009</strong>H1<br />

Operating Cashflow 2,935 3,986 1,528 1,723<br />

Net interest paid -280 -280 -125 -307<br />

Tax paid -866 -943 -455 -517<br />

Dividends paid to minorities -173 -173 -79 -112<br />

Restructuring -190 -312 -74 -82<br />

Dividends from associates 285 326 153 143<br />

Free cash flow 1,711 2,604 948 848<br />

Dividends paid to shareholders -1,198 -1,393 -954 -1,<strong>241</strong><br />

Share buy back -750 -400 -137<br />

Purchase of Bentoel -300<br />

Purchase of Tekel -873 -867 -12<br />

Purchase of ST -1,243 190<br />

Other Net Flows 152 -227 -117 -151<br />

Net cash flow -85 -1,532 -1,127 -666<br />

22


Summary<br />

� Leading Global <strong>Tobacco</strong> Company by global market share<br />

� Clear and consistent strategy that continues to deliver<br />

� Excellent geographical diversification in both developed and<br />

emerging markets<br />

� Powerful portfolio brands<br />

� Strong cash flow and liquidity positions<br />

� Solid management track record of integrating and managing<br />

assets<br />

23

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!